Anda di halaman 1dari 75

INTERNSHIP 1

By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.

EXERCISE 1

GENERAL REQUIREMENTS FOR ISSUANCE OF LTO BY BFAD

TERMS TO DEFINE
PHARMACY
DRUGS POISON

CODE
BIOLOGIC PRODUCTS WHOLESALER DEVICE CIPHER

SECRET KEYS
PHARMACEUTICAL MEDICINES

REQUIREMENTS FOR OPENING A DRUGSTORE UNDER PREMISES


Signboard
Well ventilated area nlt 15 sq.m. Compounding area, sterilization area

Storage area for drugs


Cabinet ( poisons, DD) Water supplies

REQUIREMENTS FOR OPENING A DRUGSTORE UNDER UTENSILS, APPARATUS, & EQUIPMENT


Refrigerator

BIO-REF

REQUIREMENTS FOR RENEWAL OF LTO


Standard Petition Form name, citizenship,

picture, proposed area Proof of registration

Single proprietorship cert. of business name registration (BDT of DTI) Partnerships, corporations cert. of registration (SEC) and articles of Incorporation or partnership

REQUIREMENTS FOR DRUGSTORE/RETAIL OUTLET FOR NON-RX DRUGS


Notarized petition/Joint affidavit Tentative list of products Floor area (nlt 15 sq.m) Generic white and red labels Rubber stamp of outlets Pharmacist

Registration cert. PRC-ID valid PTR ID picture cert. of attendance to BFAD seminar

Single proprietorship

Corporation
Contract of lease Picture of drugstore with signboard

Location plan and floor plan with dimension


Opening fee ( A.O. 50 s. 2001)

Requirement
Petition Form

Requirement
Joint Affidavit of

Undertaking

List of Tentative Products


Example

Paracetamol Biogesic Tempra Tylenol Winadol Acetadol Rexidol

License To Operate

Pharmacist
Registration of

certificate

Pharmacist
Business Registration

Pharmacist
PRC ID

Pharmacist
Certificate of attendance

REFERENCE BOOKS

PNDF RA 3720 RA 6675 RA 5921 RA 8203 USP/NF RPS Goodman and Gilman Pharmacological Basis of Therapeutics

Reference Book
Philippine National Drug

Formulary

Reference Book
Remington

Pharmaceutical Sciences

Reference Book
UNITED STATE

PHARMACOPEIA

RECORD BOOKS
Prescription Book
Dangerous Drug Book Poison Book

Exempt Preparation Book

Prescription Book

Prescription Book

Dangerous Drugs Book

DANGEROUS DRUG BOOK

POISON/CHEMICAL BOOK

OPIUM BOOK

PRESCRIPTION BOOK

INTERNSHIP 1

By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.

EXERCISE NO. 2

THE CONTROL OF PHARMACY PROFESSION

Terms To Define
STATUTORY LAW
COMMON LAW ETHICS

REGULATORY LAW
JURISPRUDENCE

STATUTORY LAWS AFFECTING PHARMACY PROFESSION


RA 5921 JUNE 22, 1969 RA 3720 JUNE 23, 1963 RA 8203 SEPT 4, 1996 RA 6675 1988 RA 9165 2002, repealing RA 6425 RA 9257 (Expanded Senior Citizen Act) amending RA 7432 RA 7581 PRICE ACT RA 7394 CONSUMERS ACT

THE PHARMACY LAW R.A. 5921

is an act regulating the practice of pharmacy and setting standards of pharmaceutical education in the Philippines and other purposes

THE FOODS, DRUGS & DEVICES R.A. 3720

this is an act to ensure the safety and purity of foods and cosmetics, and the purity, safety, efficacy, and quality of drugs and devices being made available to the public vesting the BFAD with authority to administer and enforce the laws pertaining thereto

SPECIAL LAW ON COUNTERFEIT DRUGS R.A. 8203 It is an act prohibiting counterfeit drugs, providing penalties for violations and appropriating funds. The BFAD of the Department of Health is authorized to administer and supervise the implementation of this Act which was approved on September 4, 1996.

THE GENERICS ACT R.A. 6675

It is act to promote, require, and ensure the production of an adequate supply, distribution, use and acceptance of drugs and medicines identified by their generic names.

COMPREHENSIVE DANGEROUS DRUG ACT R.A. 9165

It is an act instituting the Comprehensive Dangerous Drugs Act of 2002, repealing Republic Act No. 6425, otherwise known as the Dangerous Drugs Act of 1972

EXPANDED SENIOR CITIZEN ACT R.A. 9257 An act granting additional benefits and privileges to senior citizens amending for the purpose RA No. 7432, otherwise known as An act to maximize the contribution of senior citizens to nation building, grant benefits and special privileges and for other purposes

THE PRICE ACT R.A. 7581


An act providing protection to consumers by stabilizing the prices of basic necessities and prime commodities and by prescribing measures against undue price increases during emergency situations and like occasions
.

CONSUMERS ACT R.A. 7394

It is an act to protect the interest of the consumer, promote his general welfare and to establish standards of conduct for business and industry.
.

PRINCIPLES OF PROFESSIONAL CONDUCT


Service to others
Integrity and Objectivity Professional competence

Solidarity and teamwork


Social and civic responsibility Global competitiveness Equality of all professions

CODE OF ETHICS
IMPORTANCE

States publicly the principles that form the fundamental basis of pharmacists roles and responsibilities Guides them in their relationship with patients, health professionals and society

INTERNSHIP 1

By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.

EXERCISE 3

THE COMMUNITY PHARMACY PROFILE

TRADITIONAL MARKET
DRUGSTORE

PERSONNEL
STORE HOURS NON-TRADITIONAL MARKET

STORE FRONT LAYOUTS


DRUGSTORE CHAIN OPERATION MERCHANDISE &SERVICES

WAYS OF DEVELOPING COMPETITIVE ADVANTAGES IN COMMUNITY PHARMACY


Product line assortment
Leader pricing strategy Innovation of operation

Customer services
Equipment /facilities

COMPARISON OF COMMUNITY PHARMACY IN 1990S AND 2000S


Location
signboards

Store front and interiors

Staffing pattern
Pharmacist

Communication

Store facilities

Capitalization Transportation

BEING FIRST TO INTRODUCE 24 HOUR SERVICE

BEING FIRST MOTORIZED CUSTOMER DELIVERY

BEING FIRST COMPUTERIZED TEMPERATURE CONTROLLED WAREHOUSE

BEING FIRST COMMUNITY PHARMACY INSIDE SHOPPING MALLS AND SUPERMARKETS

BEING FIRST MODERNIZE STORE FRONT, INTERIORS WAREHOUSE AND LAYOUT

BEING FIRST MEDICAL-PHARMACY OUTREACH MISSION

BEING FIRST DRUGSTORE CHAIN TO EXPAND THROUGHOUT

BEING FIRST PROFESSIONALIZE ITS PERSONNEL

INTERNSHIP 1

By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.

Exercise 4

THERAPEUTIC CATEGORIES OF DRUGS BY PNDF

PNDF
DANGEROUS DRUGS BFAD

THERAPEUTIC COMMITTEES
CORE/ MAIN LIST COMPLEMENTARY LIST

GENERAL GUIDELINES FOR ESTABLISHING PNDF


Relevance to disease
Efficacy and safety Quality Cost Appropriateness to capability of health

workers at different levels of health care

Local health problems


Benefit/risk ratio Preferential factors for evaluating

therapeutically equivalent drugs Drugs formulated as single compounds Period review of drug list

Criteria for inclusion of drugs into PNDF


Drug is needed for prevention and Tx of

conditions not already covered in existing list Drug is more effective / less toxic than the drug listed for same medication Drug is at least as effective and safe and of lower cost than the drug listed for same indication Drug is essential for specific DOH health project

Criteria for deletion of drugs from PNDF


A more effective or equally effective but less

toxic drug becomes available The therapeutic efficacy of drug is found to be unsatisfactory or questionable Toxicity/suspected toxicity or potential for abuse or dangerous interactions outweigh its therapeutic value Disuse of drug and no longer available

The drug is no longer deemed cost-effective

to other therapies The drug is a fixed dose combination which does not satisfy the requirements of AO 96 s. 1990

Core List
Acetylcysteine Azathioprine Clofazimine Cobra antivenin Dantrolene Diazepam Diethylcarbamazepine Diphtheria-tetanus toxoids Dimercaprol endrophonium Ergocalciferol Fluorecein Folic acid Hydrochlorthiazide Hydrocortisone Hydroxycobalamine Indomethacin inj Iodine INH + ethambutol INH + rifampicin

INH+ Rifampicin+ PZA Levodopa + Thiacetazone Lorazepam Methylene blue N-acetyl penicillamine Neostigmine Nicotinamide ORS 75 replacement Potassium Pot. phosphate

Praziquantrel Retinol Na Ca edetate NaI 131I Na nitrite Na nitroprusside Na thiosulfate Succimer Thiamine Tuberculin purified protein derivative

Complementary List
Aciclovir eye ointment Alpha-tocopherol Al acetate Cromolyn Buserelin Busulfan Chloral hydrate Chlormethine
Dithranol

estramustine

Hydroxycobalamin Indomethacin Iodamide Iron dextran Povidone iodide Pralidoxime Cl Pyrimethamine Recombinant tissue plasminogen activator Rifabutin Rose bengal

Silver nitrate
Spectinomycin Terizodone Tetracosactide Thiacetazone

Varicella zoster Ig
Vasopressin Yerba buena Zinc

Drugs in PNDF with special requirements


Dangerous Drugs (A1)

Alprazolam Bromazepam

Morphine Nalbuphine

Butorphanol Clonazepam Codein Diazepam Fentanyl Lorazepam Methylphenidate midazolam

Oxycodone Pethidine (meperidine) Phenobarbital Thiopenthal Na Tramadol Zolpidem

Controlled precursors and Essential

chemicals (A2)

Ephedrine Ergotamine PPA

Medicinal products listed with BFAD


Akapulko
Lagundi Sambong

Tsaang gubat
Yerba buena